6 results match your criteria: "Universidade Lusofona's Research Center for Biosciences and Health Technologies (CBIOS)[Affiliation]"
Biomed Pharmacother
May 2024
Universidade Lusofona's Research Center for Biosciences and Health Technologies (CBIOS), Campo Grande 376, Lisbon 1749-024, Portugal; Instituto de Investigacao do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisboa 1649-003, Portugal. Electronic address:
The Plectranthus genus is often cited for its medicinal properties. Plectranthus ornatus Codd. is traditionally used in Africa for the treatment of gastric and liver diseases and their leaves are used for their antibiotic action.
View Article and Find Full Text PDFCureus
November 2022
Medical Oncology, University Hospital Center of Algarve, Faro, PRT.
Introduction Most cancer patients spend their last days of life in the hospital, often receiving invasive and non-palliative interventions. These patients are particularly susceptible to infections, which are a major cause of death. The decision to use antimicrobials in a palliative context is difficult, given the lack of guidelines.
View Article and Find Full Text PDFFront Chem
January 2022
Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.
Tazobactam (TazoH) is a penicillinate sulfone β-lactamase inhibitor with negligible antimicrobial activity, commonly used with other antibiotics to provide an effective combination against many susceptible organisms expressing β-lactamases. Two novel Ag(I)-tazobactam frameworks ([Ag(I)-Tazo] and [Ag(I)-Tazo]) prepared by mechanochemistry are presented herein as alternative forms to improve the antimicrobial activity of tazobactam by exploring synergistic effects with silver, being the first crystal structures reported of tazobactam coordinating to a metal site. The topological analysis of the 3D ([Ag(I)-Tazo]) and 2D+1D ([Ag(I)-Tazo]) frameworks revealed underlying nets with the (CrB self-dual) and decorated topologies, respectively.
View Article and Find Full Text PDFMolecules
May 2020
Centro de Química Estrutural (CQE), Instituto Superior Técnico (IST), Universidade de Lisboa (UL),Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal.
We report herein three novel complexes whose design was based on the approach that consists of combining commercially available antibiotics with metals to attain different physicochemical properties and promote antimicrobial activity. Thus, new isostructural three-dimensional (3D) hydrogen bonding frameworks of pipemidic acid with manganese (II), zinc (II) and calcium (II) have been synthesised by mechanochemistry and are stable under shelf conditions. Notably, the antimicrobial activity of the compounds is maintained or even increased; in particular, the activity of the complexes is augmented against , a representative of Gram-negative bacteria that have emerged as a major concern in drug resistance.
View Article and Find Full Text PDFFuture Med Chem
July 2018
Universidade Lusófona's Research Center for Biosciences and Health Technologies (CBIOS), Campo Grande 376, 1749-024 Lisbon, Portugal.
Aim: Confirm the use of Plectanthus spp. plants in traditional medicine, particularly as anti-inflammatory and anti-infective agents.
Materials & Methods: Compounds previously isolated from Plectranthus spp.
Pharmacol Res
June 2017
Universidade Lusófona's Research Center for Biosciences and Health Technologies (CBIOS), Campo Grande 376, 1749-024 Lisbon, Portugal; Biophysics and Biomedical Engineering Institute (IBEB), Faculty of Sciences, Universidade de Lisboa, Campo Grande, 1749-016 Lisbon, Portugal.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with amyloid-β peptide misfolding and aggregation. Neurotrophic factors, such as nerve growth factor (NGF), can prevent neuronal damage and rescue the cholinergic neurons that undergo cell death in AD, reverse deposition of extracellular amyloid plaques and improve cognitive deficits. However, NGF administration is hampered by the poor pharmacokinetic profile of the therapeutic protein and its inability to cross the blood-brain barrier, which requires specialised drug delivery systems (DDS) for efficient NGF delivery to the brain.
View Article and Find Full Text PDF